More

    Europe Markets

    Qaialdo | European Medicines Agency (EMA)

    OverviewQaialdo is a medicine used to manage refractory oedema (swelling due to fluid build-up that does not respond to standard treatments) associated with...

    Apretude | European Medicines Agency (EMA)

    OverviewApretude is a medicine used for preventing sexually transmitted HIV-1 infection (pre-exposure prophylaxis or PrEP) in adults and adolescents weighing at least 35...

    Zoely | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Zoely. It explains how the Committee for Medicinal Products for Human...

    Obgemsa | European Medicines Agency (EMA)

    OverviewObgemsa is a medicine used to treat adults with overactive bladder syndrome (OAB). It is used to treat symptoms of the condition such...

    Neupro | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Cimzia | European Medicines Agency (EMA)

    OverviewCimzia is a medicine that is used in adults to treat the following diseases:active rheumatoid arthritis (a disease causing inflammation of the joints)...

    Avamys | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...

    Ravicti | European Medicines Agency (EMA)

    OverviewRavicti is a medicine used to manage urea cycle disorders in adults and children, when the diseases cannot be managed by changes in...

    Onureg | European Medicines Agency (EMA)

    OverviewOnureg is a cancer medicine used to treat acute myeloid leukaemia (AML), a cancer of white blood cells.It is used for maintenance treatment...

    Big data | European Medicines Agency (EMA)

    Every day, vast amounts of data are generated that have the potential to inform and improve medicines regulation. In response, the European Medicines...

    Ulunar Breezhaler | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Ulunar Breezhaler. It explains how the Agency assessed the medicine to...

    Daptomycin Hospira | European Medicines Agency (EMA)

    OverviewDaptomycin Hospira is an antibiotic medicine used to treat the following bacterial infections:complicated infections of the skin and ‘soft tissue’ below the skin...

    Trydonis | European Medicines Agency (EMA)

    OverviewTrydonis is a medicine used in adults to relieve the symptoms of moderate to severe chronic obstructive pulmonary disease (COPD). COPD is a...

    Ruxience | European Medicines Agency (EMA)

    OverviewRuxience is a medicine used to treat the following blood cancers and inflammatory conditions:• follicular lymphoma and diffuse large B cell non-Hodgkin’s lymphoma...

    Nimenrix | European Medicines Agency (EMA)

    OverviewNimenrix is a vaccine used to protect adults, adolescents and children from the age of 6 weeks against invasive meningococcal disease caused by...

    Tabrecta | European Medicines Agency (EMA)

    OverviewTabrecta is a medicine used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC), when the cancer...